Asia-pacific Medical Collagen Market 2022-2028
MARKET OUTLOOK
A report by Triton Market Research depicts that the medical collagen market in the Asia-Pacific would progress with a CAGR of 7.23% over the forecast years from 2022 to 2028. China, India, ASEAN countries, Japan, Australia & New Zealand, South Korea, and Rest of Asia-Pacific together form the market in this region.
South Korea is witnessing a high demand for medical collagen and its market is expected to grow profoundly by the end of the forecast period. The growing acceptance by consumers for collagen products has paved the way for companies to launch new beauty products, foods, beverages, etc., in the market. In November 2021, Maypharm Co Ltd announced the launch of its new product, a PLA filler, in the market. Called MENNUS, it promotes collagen synthesis, and thus helps reduce wrinkles.
New Zealand also offers a vast growth potential to the collagen market and the companies operating in it. Marine-based collagen is extremely popular among consumers. Brands such as Dose & Co, offer a range of collagen-based products such as collagen peptides, collagen powder, and others.
Collagen products are also becoming extremely popular in the ASEAN country of Taiwan, owing to the growing consumer inclination towards beauty products. In August 2021, Maxigen Biotech Inc launched a collagen product called MAXI Collagen in the Taiwanese market. Prepared using double enzyme hydrolysis, it is highly beneficial for the skin.
COMPETITIVE OUTLOOK
The prominent companies in the medical collagen market are Symatese, DSM, Jellagen, Lapi Gelatine, Italgel, Stryker, Integra Life Sciences, and Darling Ingredients Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook